Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban vs. Warfarin in Patients With Mechanical Heart Valves

NCT07456085 is registered in ClinicalTrials.gov with Rawalpindi Institute of Cardiology as lead sponsor.

NCT NCT07456085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07456085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban vs. Warfarin in Patients With Mechanical Heart Valves
Lead sponsor
Rawalpindi Institute of Cardiology
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
November 13, 2025
Completion date
April 12, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

valvular heart disease patients